Risk factors for mortality in patients with Staphylococcus aureus bloodstream infection
- PMID: 26431371
- DOI: 10.1179/1973947815Y.0000000076
Risk factors for mortality in patients with Staphylococcus aureus bloodstream infection
Abstract
In this two year retrospective analysis, we evaluated the epidemiology and risk factors for mortality of Staphylococcus aureus bloodstream infection (SaBSI). Methicillin-susceptible S. aureus (MSSA) was isolated in 84 (44.2%) and methicillin-resistant S. aureus (MRSA) in 106 episodes (55.8%). The mortality rate after 21 days was 16.4%. At univariate analysis older age, no removal of central venous catheter (CVC), prosthetic heart valves, severe sepsis, septic shock and high APACHE II score were significantly associated with mortality, whereas treatment duration > 48 hours, appropriate targeted therapy and prolonged treatment duration were significantly associated with survival. At multivariate analysis, prosthetic valves, septic shock and fever 48 hours after the diagnosis were significantly related to mortality. In this study, the mortality was associated with clinical rather than microbiological factors.
Keywords: Bloodstream infection; Mortality; Risk factors; Staphylococcus aureus.
Similar articles
-
Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus.Infect Control Hosp Epidemiol. 2007 Mar;28(3):273-9. doi: 10.1086/512627. Epub 2007 Feb 15. Infect Control Hosp Epidemiol. 2007. PMID: 17326017
-
Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006.J Infect Dis. 2008 Aug 1;198(3):336-43. doi: 10.1086/589717. J Infect Dis. 2008. PMID: 18522502
-
Predictive factors for mortality in patients with methicillin-resistant Staphylococcus aureus bloodstream infection: impact on outcome of host, microorganism and therapy.Clin Microbiol Infect. 2013 Nov;19(11):1049-57. doi: 10.1111/1469-0691.12108. Epub 2013 Jan 17. Clin Microbiol Infect. 2013. PMID: 23331461
-
[Staphylococcus aureus bacteremia - a distinct entity].Dtsch Med Wochenschr. 2015 Jun;140(13):982-9. doi: 10.1055/s-0041-102453. Epub 2015 Jun 26. Dtsch Med Wochenschr. 2015. PMID: 26115133 Review. German.
-
Future strategies for treating Staphylococcus aureus bloodstream infections.Clin Microbiol Infect. 2008 Mar;14 Suppl 2:26-34. doi: 10.1111/j.1469-0691.2008.01924.x. Clin Microbiol Infect. 2008. PMID: 18226087 Review.
Cited by
-
Identification of Methicillin-Resistant Staphylococcus Aureus From Methicillin-Sensitive Staphylococcus Aureus and Molecular Characterization in Quanzhou, China.Front Cell Dev Biol. 2021 Jan 21;9:629681. doi: 10.3389/fcell.2021.629681. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33553185 Free PMC article.
-
Staphylococcal Scalded Skin Syndrome in Child. A Case Report and a Review from Literature.J Crit Care Med (Targu Mures). 2016 Nov 8;2(4):192-197. doi: 10.1515/jccm-2016-0028. eCollection 2016 Oct. J Crit Care Med (Targu Mures). 2016. PMID: 29967859 Free PMC article.
-
Staphylococcal Toxic Shock Syndrome Caused by an Intravaginal Product. A Case Report.J Crit Care Med (Targu Mures). 2016 Feb 9;2(1):51-55. doi: 10.1515/jccm-2016-0003. eCollection 2016 Jan. J Crit Care Med (Targu Mures). 2016. PMID: 29967837 Free PMC article.
-
Influence of Reported Penicillin Allergy on Mortality in MSSA Bacteremia.Open Forum Infect Dis. 2018 Feb 19;5(3):ofy042. doi: 10.1093/ofid/ofy042. eCollection 2018 Mar. Open Forum Infect Dis. 2018. PMID: 29594180 Free PMC article.
-
Outcomes of Vancomycin plus a β-Lactam versus Vancomycin Only for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia.Antimicrob Agents Chemother. 2018 Jan 25;62(2):e01554-17. doi: 10.1128/AAC.01554-17. Print 2018 Feb. Antimicrob Agents Chemother. 2018. PMID: 29133561 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical